Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chemotherapy in the elderly

N Wilking1

  • 1Radiumhemmet, Karolinska Hospital, Stockholm, Sweden. nwi@rah.ks.se

European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
|November 4, 1998
PubMed
Summary

Chemotherapy for elderly cancer patients requires careful consideration due to age-related organ decline and functional limitations. Treatment strategies must adapt to individual patient needs, including social and economic factors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Access to novel cancer medicines in Europe: inequities across countries and their drivers.

ESMO open·2025
Same author

Insights into cancer surveillance in Central and Eastern Europe, Israel and Turkey.

European journal of cancer care·2014
Same author

Angiogenic factors in relation to clinical effect in a phase II trial of weekly paclitaxel.

Breast (Edinburgh, Scotland)·2013
Same author

Differential-effects of fibroblast coculture on mcf-7 and mda-231 breast-carcinoma cell invasion through matrigel.

Oncology reports·2011
Same author

Health-related quality of life during hormone therapy after breast cancer: a randomized trial.

Climacteric : the journal of the International Menopause Society·2010
Same author

Hormone replacement therapy after breast cancer: attitudes of women eligible in a randomized trial.

Climacteric : the journal of the International Menopause Society·2009

Area of Science:

  • Geriatric Oncology
  • Cancer Treatment
  • Pharmacology

Background:

  • Cancer incidence is rising, largely due to an aging global population.
  • Elderly cancer patients often have a life expectancy exceeding the prognosis of their disease.
  • Age-related physiological changes present unique challenges for cancer therapy.

Purpose of the Study:

  • To highlight the specific challenges of chemotherapy in elderly cancer patients.
  • To advocate for modified approaches to chemotherapy indications and agent selection in this demographic.
  • To emphasize the importance of considering multifactorial patient characteristics.

Main Methods:

  • Review of current literature on geriatric oncology and chemotherapy.
  • Analysis of age-related physiological changes impacting drug efficacy and toxicity.
  • Consideration of psychosocial and economic factors in treatment planning.

Main Results:

  • Significant decline in renal and cardiac function is common in the elderly.
  • Sensory and mobility impairments can affect treatment adherence and quality of life.
  • Standard chemotherapy regimens may require dose adjustments or alternative agents.

Conclusions:

  • Chemotherapy in elderly patients necessitates a personalized approach.
  • Treatment decisions must balance potential benefits against age-related risks and functional status.
  • Integrated care considering medical, social, and economic factors is crucial for optimal outcomes.

Related Experiment Videos